Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.
Novartis
Novartis
Orca Biosystems, Inc.
Center for International Blood and Marrow Transplant Research
Takeda
Cogent Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Fred Hutchinson Cancer Center
Cogent Biosciences, Inc.
Masonic Cancer Center, University of Minnesota
Sierra Oncology LLC - a GSK company
Baptist Health South Florida
Hoffmann-La Roche
Novartis
Gilead Sciences
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Sunesis Pharmaceuticals
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
National Heart, Lung, and Blood Institute (NHLBI)
Seagen Inc.
M.D. Anderson Cancer Center
Scios, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Copenhagen University Hospital at Herlev
University of Cincinnati